Answers are grounded in this paper and cite their sources.
BACKGROUND: Recently updated sepsis management guidelines no longer exclude albumin from initial fluid resuscitation as understanding of the microvascular pathophysiology differentiating sepsis from septic shock continues to evolve. OBJECTIVES: To determine whether albumin administration compared to crystalloid administration reduces 90-day mortality in adults with septic shock. RESEARCH PLAN: The Joanna Briggs Institute methodology for systematic reviews was used. PubMed, Embase, and CINAHL were searched from 2014 to 2026 using the terms, "albumin AND fluid resuscitation AND sepsis AND crystalloid." METHODS: After screening and eligibility assessment, three systematic reviews with meta-analyses were included. Outcomes associated with albumin-based and crystalloid-based resuscitation strategies in patients with sepsis and septic shock were compared. CONCLUSION: Two of the three meta-analyses demonstrated a statistically significant reduction in 90-day mortality among septic shock patients resuscitated with albumin compared with crystalloid. Hyperoncotic albumin (20% or 25%) may provide additional benefit when administered at an appropriate time during resuscitation. Evidence suggests that early administration of hyperoncotic albumin following an initial 30mL/kg balanced crystalloid bolus may improve mortality outcomes in patients with septic shock. IMPLICATIONS FOR PRACTICE: Incorporating measures of microvascular and endothelial changes may help guide the selective use of hyperoncotic 20% albumin following initial crystalloid resuscitation and improve patient outcomes.
No takes yet. Share an insight, caveat, or question.
Molly McCann (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: